Engebraaten, Olav

Fatigue During and After Breast Cancer Therapy—A Prospective Study

Reinertsen, K. V., Engebraaten, O., Loge, J. H., Cvancarova, M., Naume, B., Wist, E., Edvardsen, H., Wille, E., Bjøro, T., & Kiserud, C. E. (2017) · Journal of Pain and Symptom Management

Cancer survivorship and careCancer-related cognitive impairment studies

Cited by 71

Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer

Krüger, K., Silwal-Pandit, L., Wik, E., Straume, O., Stefansson, I. M., Borgen, E., Garred, Ø., Naume, B., Engebraaten, O., & Akslen, L. A. (2021) · Scientific Reports

Breast Cancer Treatment StudiesAngiogenesis and VEGF in Cancer

Cited by 32

Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer

von der Lippe Gythfeldt, H., Lien, T., Tekpli, X., Silwal‐Pandit, L., Borgen, E., Garred, Ø., Skjerven, H., Schlichting, E., Lundgren, S., Wist, E., et al. (2020) · International Journal of Cancer

Breast Cancer Treatment StudiesAngiogenesis and VEGF in Cancer

Cited by 20